Biocon Ltd
Biocon Ltd (BIOCON) last traded at ₹415, a market capitalisation of ₹67,567 crore, on a P/E of 92.9. Over the past 52 weeks the stock has ranged between ₹337 and ₹447. Biocon Ltd last reported results for the quarter ended Jun 2026, with sales of ₹4,336 crore and net profit of ₹137 crore. Figures are as of 25 Aug 2026 and are not real time.
Biocon Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Biocon Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹4,336 cr, up 10.0% from ₹3,942 cr a year earlier. Net profit was ₹137 cr, up 53.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3,590 | 3,821 | 4,417 | 3,942 | 4,296 | 4,173 | 4,517 | 4,336 |
| Expenses | 2,905 | 3,070 | 3,339 | 3,176 | 3,460 | 3,340 | 3,496 | 3,489 |
| Operating profit | 685 | 752 | 1,078 | 766 | 835 | 834 | 1,020 | 847 |
| OPM % | 19% | 20% | 24% | 19% | 19% | 20% | 23% | 20% |
| Other income | 58 | 53 | 57 | 62 | 81 | -176 | -28 | 41 |
| Interest | 226 | 223 | 212 | 277 | 272 | 210 | 232 | 213 |
| Depreciation | 420 | 425 | 436 | 455 | 473 | 515 | 513 | 547 |
| Profit before tax | 98 | 156 | 487 | 97 | 171 | -68 | 248 | 128 |
| Tax % | 72% | 48% | 6% | 8% | 22% | -24% | 20% | -7% |
| Net profit | 27 | 81 | 459 | 89 | 133 | -52 | 199 | 137 |
| EPS (₹) | -0.13 | 0.21 | 2.87 | 0.23 | 0.63 | 1.08 | 0.78 | 0.87 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Biocon Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 7,143 | 8,184 | 11,174 | 14,756 | 15,262 | 16,927 | 17,321 |
| Operating profit | 1,581 | 1,793 | 2,412 | 3,216 | 3,254 | 3,471 | 3,536 |
| OPM % | 22% | 22% | 22% | 22% | 21% | 21% | 20% |
| Net profit | 846 | 772 | 643 | 1,298 | 1,429 | 369 | 416 |
| EPS (₹) | 6.17 | 5.40 | 3.85 | 8.52 | 8.44 | 2.38 | 3.36 |
TTM is the trailing twelve months to the most recent quarter.
Biocon Ltd growth and returns
- 10 Years
- 18%
- 5 Years
- 19%
- 3 Years
- 15%
- TTM
- 10%
- 10 Years
- 1%
- 5 Years
- -12%
- 3 Years
- -15%
- TTM
- 100%
- 10 Years
- 11%
- 5 Years
- 4%
- 3 Years
- 17%
- 1 Year
- 14%
- 10 Years
- 6%
- 5 Years
- 4%
- 3 Years
- 3%
- Last Year
- 1%
Biocon Ltd shareholding pattern
Promoters held 44.68% at Jun 2026, down from 54.45% at Jun 2025. FIIs 8.14% and DIIs 23.33%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 60.64% | 60.64% | 60.64% | 54.45% | 54.45% | 54.45% | 44.91% | 44.68% |
| FIIs | 5.93% | 5.66% | 5.67% | 6.04% | 6.61% | 7.39% | 7.52% | 8.14% |
| DIIs | 14.44% | 15.36% | 15.73% | 22.83% | 22.06% | 21.67% | 24.01% | 23.33% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.03% | 0.05% | 0.05% |
| Public | 18.74% | 18.11% | 17.77% | 16.51% | 16.70% | 16.34% | 23.40% | 23.75% |
| No. of shareholders | 4,39,503 | 4,27,705 | 4,24,297 | 4,28,131 | 4,13,191 | 3,94,279 | 3,86,593 | 3,92,833 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Biocon Ltd corporate filings
- Company StatementCompany Updatelow impact
Cruxal's analysis: Biocon Ltd has released a general company statement dated August 25, 2026. The disclosure…
Read the full analysis - Company StatementCompany Updatelow impact
Cruxal's analysis: Biocon Ltd has released a general company statement dated August 18, 2026. The filing…
Read the full analysis - Investor MeetCompany Updatelow impact
Cruxal's analysis: Biocon Ltd has issued an intimation regarding an upcoming analyst/investor meet. The…
Read the full analysis - Earning call Transcript for Q1 FY27Company Updatehigh impact
Cruxal's analysis: Biocon Limited reported a 10% year-on-year growth in operating revenue for Q1 FY27, with…
Read the full analysis - Voting Results and Scrutinizer''s reportAGM/EGMmedium impact
Cruxal's analysis: Biocon Limited has successfully concluded its 48th Annual General Meeting held on August…
Read the full analysis - Investor MeetCompany Updatelow impact
Cruxal's analysis: Biocon Ltd has issued an intimation regarding an upcoming analyst/investor meet. The…
Read the full analysis - Newspaper AdvertisementCompany Updatelow impact
Cruxal's analysis: Biocon Ltd has published a statutory newspaper advertisement regarding its financial…
Read the full analysis - Resignation of Statutory auditors of material subsidiaries of the Company.Company Updatelow impact
Cruxal's analysis: Biocon Limited has disclosed that B S R & Co. LLP has resigned as the statutory auditor…
Read the full analysis - Completion of tenure of Statutory AuditorsCompany Updatelow impact
Cruxal's analysis: Biocon Ltd has formally notified the completion of the tenure of its statutory auditors…
Read the full analysis - Change in DirectorateCompany Updatelow impact
Cruxal's analysis: Biocon Limited has formalized key governance changes following its 48th Annual General…
Read the full analysis - Proceedings of the 48th AGM of the Company and the Chairperson''s speech.AGM/EGMlow impact
Cruxal's analysis: Biocon Limited held its 48th Annual General Meeting on August 06, 2026, confirming the…
Read the full analysis - Audio and video recording of Q1 2027Company Updatelow impact
Cruxal's analysis: Biocon Ltd has made available the audio and video recordings of its analyst and investor…
Read the full analysis - Investor PresentationCompany Updatemedium impact
Cruxal's analysis: Biocon Limited reported Q1 FY27 total revenue of 4,391 crore, a 9% YoY increase, with…
Read the full analysis - Monitoring Agency ReportCompany Updatelow impact
Cruxal's analysis: Biocon Ltd has submitted a Monitoring Agency Report in compliance with Regulation 30 of…
Read the full analysis - Press ReleaseCompany Updatelow impact
Cruxal's analysis: Biocon Ltd has submitted a press release under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Outcome of Board Meeting- Financial ResultsResultmedium impact
Cruxal's analysis: Biocon Limited reported consolidated revenue from operations of 4,336 crore for the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Biocon Ltd
Cruxal reads every Biocon Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.